P

Inventor

SADELAIN MICHEL

US34 patents
⚠️ This page may combine multiple inventors who share the name “SADELAIN MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEMORIAL SLOAN KETTERING CANCER CENTER

25 patents
US10117897B2Nov 6, 2018

Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes

MEMORIAL SLOAN KETTERING CANCER CENTER13 citations92
US10370452B2Aug 6, 2019

Effective generation of tumor-targeted T cells derived from pluripotent stem cells

MEMORIAL SLOAN KETTERING CANCER CENTER21 citations88
US11242375B2Feb 8, 2022

Immune cell compositions and methods of use

MEMORIAL SLOAN KETTERING CANCER CENTER5 citations83
US10654928B2May 19, 2020

Compositions and methods for immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER12 citations83
US10730941B2Aug 4, 2020

Antigen-binding proteins targeting CD56 and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER10 citations82
US11267901B2Mar 8, 2022

Compositions and methods for immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER12 citations81
US12263220B2Apr 1, 2025

Compositions and methods for immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER1 citations72
US11702472B2Jul 18, 2023

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations72
US10633441B2Apr 28, 2020

Mesothelin-targeted chimeric antigen receptors and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations72
US10538588B2Jan 21, 2020

Mesothelin-targeted chimeric antigen receptors and methods of making them

MEMORIAL SLOAN KETTERING CANCER CENTER1 citations72
US11717579B2Aug 8, 2023

Globin gene therapy for treating hemoglobinopathies

MEMORIAL SLOAN KETTERING CANCER CENTER3 citations68
US11932690B2Mar 19, 2024

Enhanced chimeric antigen receptors and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER4 citations66
US11229669B2Jan 25, 2022

Cells comprising non-HLA restricted T cell receptors

MEMORIAL SLOAN KETTERING CANCER CENTER3 citations66
US10350243B2Jul 16, 2019

Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursors

MEMORIAL SLOAN KETTERING CANCER CENTER3 citations65
US11753654B2Sep 12, 2023

Globin gene therapy for treating hemoglobinopathies

MEMORIAL SLOAN KETTERING CANCER CENTER2 citations64
US11077140B2Aug 3, 2021

Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations62
US12139524B2Nov 12, 2024

Immune cell compositions and methods of use

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations61
US12275802B2Apr 15, 2025

Compositions and methods for immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER1 citations60
US12018077B2Jun 25, 2024

Methods of treatments using antigen-binding proteins targeting CD56

MEMORIAL SLOAN KETTERING CANCER CENTER1 citations60
US11712469B2Aug 1, 2023

Compositions and methods for immunotherapy

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations60
US12345712B2Jul 1, 2025

Cancer antigen targets and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US12259390B2Mar 25, 2025

Cancer antigen targets and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US11193938B2Dec 7, 2021

Cancer antigen targets and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations57
US12036244B2Jul 16, 2024

Cells comprising non-HLA restricted T cell receptors

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations56
US12331129B2Jun 17, 2025

Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof

MEMORIAL SLOAN KETTERING CANCER CENTER0 citations44

SLOAN KETTERING INST CANCER

5 patents

SADELAIN MICHEL

3 patents

ZAKRZEWSKI JOHANNES L

1 patent